leisure time -WSS

leisure time

author：hotspot 2025-10-01 01:49:40 - browse：156

glum Benjamin — health insurance coverage from STAT — Adobe

Three biotech VC veterans, including one of the co-founders of radiopharma success story RayzeBio, are launching a new investment fund called Scion Life Sciences.

Scion was started by former Apple Tree Partners colleagues Sam Hall and Aaron Kantoff, along with Tadd Wessel, managing partner of the health care private equity firm Petrichor. They raised $310 million for its first fund, blowing past their original $250 million target.

They’re planning on taking a different tack with biotech venture capital. For starters, Scion plans to work on a significantly longer timeframe. Most firms in existence today write checks, help investments grow, and find a way to recoup their money in a 10-year timeframe. Scion is doubling that, setting a 20-year plan for its first fund.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Federal weight loss drug coverage is 30 years out of date

WSS

Designating disabled people as health disparity population is crucial

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Burning questions for the 2024 JPM Healthcare Conference

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

JPM 2024: Verve Therapeutics looks to mainstream genome editing

hotspot

leisure time

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

3 medical device trends to watch in 2024

How to save PrEP access — and even expand it

AdventHealth escalates lawsuit against insurance vendor Multiplan

Tori Bowie and the unacceptable rates of Black maternal death

How I ended up pumping milk in a bathroom stall at JPM 2024

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Heart disease and mental health: A look at cardiac psychology

BioMarin wins approval for gene therapy to treat hemophilia A

The nurse manager staffing crisis is hurting patients

entertainment

Goldman Sachs launches $650M fund for life science investments

Generative AI mines health records to identify patients’ social needs

New weight loss drugs work. But how can they best be used?

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

Why psychiatrists like me stop taking insurance

The FDA must approve intranasal treatments for anaphylaxis

hotspot

knowledge

explore

leisure time